P127 Efficacy and safety of trastuzumab biosimilar Abdi Ibrahim in the neoadjuvant setting for HER2 positive breast cancer: about 40 cases.
Autor: | Nèche, N., Kouadri, N., Djedi, H. |
---|---|
Předmět: | |
Zdroj: | Breast; 2023 Supplement, Vol. 68, pS64-S64, 1p |
Databáze: | Supplemental Index |
Externí odkaz: |